Rebamipide Reprograms Hepatic Networks to Prevent and Reverse Metabolic-Dysfunction-Associated Steatotic Liver Disease: Multi-Omics Insights and Histological Validation.

Pharmaceuticals (Basel) · 2026 · PMC13119257 · PMID 42075815

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Interestingly, morphometrical analysis of the percentage of activated Ito cells demonstrated a highly significant increase in both the model and Reb T1 groups compared with the control group, whereas no significant difference was observed between the control and Reb T2 groups.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.